Synmosa Biopharma (Taiwan) Price History

4114 Stock  TWD 34.20  0.10  0.29%   
If you're considering investing in Synmosa Stock, it is important to understand the factors that can impact its price. As of today, the current price of Synmosa Biopharma stands at 34.20, as last reported on the 29th of March, with the highest price reaching 34.80 and the lowest price hitting 34.00 during the day. Synmosa Biopharma owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0131, which indicates the firm had a -0.0131 % return per unit of risk over the last 3 months. Synmosa Biopharma exposes twenty-nine different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Synmosa Biopharma's Risk Adjusted Performance of 0.0796, semi deviation of 0.656, and Coefficient Of Variation of 1102.59 to confirm the risk estimate we provide.
  
Synmosa Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0131

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns4114

Estimated Market Risk

 0.89
  actual daily
7
93% of assets are more volatile

Expected Return

 -0.01
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.01
  actual daily
0
Most of other assets perform better
Based on monthly moving average Synmosa Biopharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Synmosa Biopharma by adding Synmosa Biopharma to a well-diversified portfolio.

Synmosa Biopharma Stock Price History Chart

There are several ways to analyze Synmosa Stock price data. The simplest method is using a basic Synmosa candlestick price chart, which shows Synmosa Biopharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceDecember 26, 202435.05
Lowest PriceMarch 4, 202532.55

Synmosa Biopharma March 29, 2025 Stock Price Synopsis

Various analyses of Synmosa Biopharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Synmosa Stock. It can be used to describe the percentage change in the price of Synmosa Biopharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Synmosa Stock.
Synmosa Biopharma Price Daily Balance Of Power 0.13 
Synmosa Biopharma Price Rate Of Daily Change 1.00 
Synmosa Biopharma Price Action Indicator(0.15)
Synmosa Biopharma Accumulation Distribution 55,465 

Synmosa Biopharma March 29, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Synmosa Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Synmosa Biopharma intraday prices and daily technical indicators to check the level of noise trading in Synmosa Stock and then apply it to test your longer-term investment strategies against Synmosa.

Synmosa Stock Price History Data

The price series of Synmosa Biopharma for the period between Sun, Dec 29, 2024 and Sat, Mar 29, 2025 has a statistical range of 2.8 with a coefficient of variation of 1.82. The prices are distributed with arithmetic mean of 33.62. The median price for the last 90 days is 33.55. The company had 1000000:1101600 stock split on 9th of August 2024. Synmosa Biopharma issued dividends on 2022-07-11.
OpenHighLowCloseVolume
03/28/2025 34.40  34.80  34.00  34.20  2,412,711 
03/27/2025 34.25  34.25  33.95  34.10  547,485 
03/26/2025 34.10  34.25  34.05  34.25  372,676 
03/25/2025 34.15  34.20  33.75  34.10  1,174,186 
03/24/2025 34.55  34.55  34.10  34.15  572,564 
03/21/2025 34.45  34.55  34.20  34.45  1,506,330 
03/20/2025 34.00  34.10  33.80  33.90  430,972 
03/19/2025 34.20  34.25  33.85  33.90  743,478 
03/18/2025 34.35  34.40  34.10  34.15  853,090 
03/17/2025 34.10  35.05  34.10  34.30  3,641,140 
03/14/2025 33.50  34.20  33.50  34.00  2,335,831 
03/13/2025 33.25  33.80  33.25  33.50  3,416,090 
03/12/2025 33.30  33.45  33.15  33.20  846,749 
03/11/2025 32.95  33.25  32.60  33.25  1,306,578 
03/10/2025 33.20  33.25  32.85  33.05  783,811 
03/07/2025 32.70  33.15  32.70  33.05  1,054,262 
03/06/2025 33.20  33.35  33.05  33.25  972,117 
03/05/2025 32.65  33.25  32.65  33.20  1,915,668 
03/04/2025 32.60  32.60  32.35  32.55  1,417,842 
03/03/2025 32.60  33.05  32.50  32.75  2,219,201 
02/27/2025 32.95  33.00  32.65  32.70  9,780,474 
02/26/2025 33.40  33.40  33.10  33.15  1,395,517 
02/25/2025 33.15  33.50  33.10  33.45  2,703,115 
02/24/2025 32.90  33.05  32.75  32.85  2,159,468 
02/21/2025 32.90  32.95  32.80  32.90  1,206,535 
02/20/2025 33.05  33.10  32.90  32.90  1,334,286 
02/19/2025 33.15  33.20  33.00  33.05  2,324,372 
02/18/2025 33.20  33.25  33.15  33.15  1,070,722 
02/17/2025 33.35  33.35  33.15  33.20  1,094,229 
02/14/2025 33.25  33.35  33.00  33.35  1,336,085 
02/13/2025 33.35  33.40  33.20  33.30  1,223,928 
02/12/2025 33.50  33.75  33.35  33.35  703,925 
02/11/2025 33.80  33.95  33.60  33.60  425,173 
02/10/2025 33.75  34.00  33.70  33.75  424,543 
02/07/2025 34.30  34.30  33.90  33.95  521,676 
02/06/2025 33.75  34.35  33.65  34.30  1,262,827 
02/05/2025 33.85  33.85  33.55  33.55  607,413 
02/04/2025 33.75  33.90  33.50  33.55  510,533 
02/03/2025 33.35  33.60  33.10  33.45  858,971 
01/22/2025 33.35  33.40  33.00  33.40  572,000 
01/21/2025 33.00  33.40  33.00  33.00  530,000 
01/20/2025 33.20  33.20  33.05  33.05  526,000 
01/17/2025 33.30  33.45  33.20  33.30  304,000 
01/16/2025 33.25  33.60  33.15  33.20  763,000 
01/15/2025 33.85  33.90  33.10  33.20  867,000 
01/14/2025 33.85  34.10  33.85  33.90  271,000 
01/13/2025 34.55  34.75  33.70  33.80  1,017,000 
01/10/2025 35.20  35.35  34.35  34.40  879,000 
01/09/2025 35.00  35.40  34.90  34.90  2,600,000 
01/08/2025 34.40  34.75  34.35  34.45  692,000 
01/07/2025 34.50  34.50  34.05  34.05  415,000 
01/06/2025 34.05  34.60  34.05  34.30  541,000 
01/03/2025 34.45  34.50  34.05  34.10  633,000 
01/02/2025 34.50  34.80  34.25  34.25  525,000 
12/31/2024 34.80  34.80  34.35  34.50  376,000 
12/30/2024 35.05  35.05  34.45  34.50  671,000 
12/27/2024 35.50  35.75  34.70  34.70  2,414,000 
12/26/2024 33.60  35.15  33.60  35.05  2,737,000 
12/25/2024 33.95  33.95  33.50  33.70  340,000 
12/24/2024 33.75  33.95  33.60  33.75  444,000 
12/23/2024 33.55  33.75  33.50  33.60  447,000 

About Synmosa Biopharma Stock history

Synmosa Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Synmosa is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Synmosa Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Synmosa Biopharma stock prices may prove useful in developing a viable investing in Synmosa Biopharma
Synmosa Biopharma Corporation, a specialty pharmaceutical company, researches and develops, manufactures, markets, and distributes pharmaceutical and healthcare products under the Synmosa brand name in Taiwan. The company was incorporated in 1980 and is based in Taipei, Taiwan. SYNMOSA BIOPHARMA operates under Drug ManufacturersSpecialty Generic classification in Taiwan and is traded on Taiwan OTC Exchange.

Synmosa Biopharma Stock Technical Analysis

Synmosa Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Synmosa Biopharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Synmosa Biopharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Sign In To Macroaxis Now

   

Sign In To Macroaxis

Sign in to explore Macroaxis' wealth optimization platform and fintech modules
All  Next Launch Module

Synmosa Biopharma Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Synmosa Biopharma's price direction in advance. Along with the technical and fundamental analysis of Synmosa Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Synmosa to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Synmosa Stock Analysis

When running Synmosa Biopharma's price analysis, check to measure Synmosa Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Synmosa Biopharma is operating at the current time. Most of Synmosa Biopharma's value examination focuses on studying past and present price action to predict the probability of Synmosa Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Synmosa Biopharma's price. Additionally, you may evaluate how the addition of Synmosa Biopharma to your portfolios can decrease your overall portfolio volatility.